Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Front Immunol ; 15: 1405452, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38915401

RESUMEN

Introduction: Chimeric antigen receptor (CAR) T-cell therapy (CAR T therapy) is a treatment option for patients with relapsed or refractory multiple myeloma that has led to unprecedented treatment outcomes. Among CAR T therapies available, ciltacabtagene autoleucel (cilta-cel) is a good candidate for outpatient administration due to its generally predictable safety profile. There are multiple advantages of outpatient administration of cilta-cel, including reduced healthcare burden, expanded access, and patient autonomy. This mixed methods qualitative study aimed to identify key factors for outpatient administration of CAR T and best practice recommendations by combining a targeted literature review with expert interviews and panels. Methods: The targeted review (Phase 1) aimed to identify factors for outpatient CAR T administration in the US and determine key topics for the exploratory interviews (Phase 2) and expert panels (Phase 3), which aimed to inform on best practices and challenges of outpatient CAR T administration (focusing on cilta-cel). Participants in clinical and administrative positions based in treatment centers that had experience with real-world outpatient administration of cilta-cel were recruited. Results: Seventeen studies were identified in Phase 1. Key factors for outpatient administration included the development of protocols for CAR T complications, education for caregivers, outpatient specialists, hospital staff, and emergency services staff for identification and referral after possible adverse events, the creation of multidisciplinary teams for effective communication and management, straightforward patient intake processes encompassing financial eligibility review and provision of patient education materials, and close patient monitoring throughout the treatment journey. In Phase 2, 5 participants from 2 centers were interviewed. In Phase 3, 14 participants across 6 treatment centers were interviewed. Two 90-minute virtual panel discussions took place. All participants agreed that cilta-cel can be safely and effectively administered in an outpatient setting. Key recommendations included the creation of educational resources for patients and caregivers, the development of standard operating procedures, dedicated outpatient infrastructure and establishment of interdisciplinary teams, outpatient monitoring for toxicity management, and monitoring of the reimbursement landscape. Discussion: This study offers a comprehensive understanding of the feasibility of outpatient cilta-cel administration in participating CAR T centers and provides actionable recommendations while acknowledging existing challenges.


Asunto(s)
Inmunoterapia Adoptiva , Mieloma Múltiple , Humanos , Mieloma Múltiple/terapia , Mieloma Múltiple/tratamiento farmacológico , Mieloma Múltiple/inmunología , Inmunoterapia Adoptiva/efectos adversos , Inmunoterapia Adoptiva/métodos , Pacientes Ambulatorios , Productos Biológicos/uso terapéutico , Productos Biológicos/administración & dosificación , Productos Biológicos/efectos adversos , Atención Ambulatoria , Receptores Quiméricos de Antígenos/inmunología , Masculino
2.
Health Psychol ; 26(5): 577-87, 2007 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-17845109

RESUMEN

OBJECTIVE: To examine the putative determinants of two osteoporosis-preventive behaviors, calcium consumption and weight-bearing exercise, in 2 samples of young women (Sample 1, n = 202; Sample 2, n = 209). A common psychosocial model of both behaviors, comprising the health belief model and augmented with constructs drawn from social cognitive theory and the theory of planned behavior, was developed, tested, and replicated. DESIGN: A prospective 2-panel design was used. Baseline data were obtained in fall 1997 for Sample 1 and in spring 2002 for Sample 2. Behavioral follow-up data were obtained 6 months after initial data collection for both samples. MAIN OUTCOME MEASURES: Baseline measures of behavioral intentions served as proximal outcomes. Behavioral measures obtained 6 months later served as distal outcomes. RESULTS: Perceived barriers and self-efficacy directly predicted intentions to consume calcium and to exercise. Descriptive norms predicted intentions, in part indirectly through barriers and self-efficacy. Constructs specific to osteoporosis (e.g., susceptibility, severity) did not contribute to prediction. With initial behavior controlled, intentions to consume calcium and to exercise predicted the corresponding behaviors measured 6 months later; intentions fully mediated the relationship of model constructs to behavior. CONCLUSION: Health beliefs associated with a negative health outcome, here osteoporosis, distal to young women's lives did not contribute to prediction. In contrast, constructs related to the current behaviors of calcium consumption and weight-bearing exercise (barriers, self-efficacy, norms) were highly predictive. Implications for behavioral interventions are discussed.


Asunto(s)
Calcio/administración & dosificación , Modelos Teóricos , Osteoporosis/prevención & control , Psicología , Levantamiento de Peso , Adolescente , Adulto , Arizona , Femenino , Humanos , Estudios Prospectivos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA